Cargando…
A multi‐analyte cell‐free DNA–based blood test for early detection of hepatocellular carcinoma
The limited performance of guideline‐recommended abdominal ultrasound and serum alpha‐fetoprotein (AFP) highlights the urgent, unmet need for new biomarkers for more accurate detection of early hepatocellular carcinoma (HCC). To this end, we have conducted a prospective clinical validation study to...
Autores principales: | Lin, Nan, Lin, Yongping, Xu, Jianfeng, Liu, Dan, Li, Diange, Meng, Hongyu, Gallant, Maxime A., Kubota, Naoto, Roy, Dhruvajyoti, Li, Jason S., Gorospe, Emmanuel C., Sherman, Morris, Gish, Robert G., Abou‐Alfa, Ghassan K., Nguyen, Mindie H., Taggart, David J., Van Etten, Richard A., Hoshida, Yujin, Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234637/ https://www.ncbi.nlm.nih.gov/pubmed/35244350 http://dx.doi.org/10.1002/hep4.1918 |
Ejemplares similares
-
Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk
por: Kubota, Naoto, et al.
Publicado: (2020) -
Patient advocacy and the future of systemic therapies in liver cancer: an interview with Ghassan Abou-Alfa
por: Abou-Alfa, Ghassan
Publicado: (2020) -
ESMO presidential symposium wrap up: the ClarIDHy trial
por: Abou-Alfa, Ghassan K
Publicado: (2020) -
Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management
por: Abou-Alfa, Ghassan K., et al.
Publicado: (2023) -
Treatment options after sorafenib failure in patients with hepatocellular carcinoma
por: Dika, Imane El, et al.
Publicado: (2017)